Suchergebnisse - "Das, Sharmila"

PubPharm (23)

1

USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2024

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

2

골수섬유증과 같은 혈액 악성종양을 치료하기 위한 BET 억제제 단독 또는 페드라티닙 또는 룩솔리티닙과의 조합물의 용도

enthalten in: Europäisches Patentamt | 2023

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

3

골수섬유증과 같은 혈액 악성종양을 치료하기 위한 BET 억제제 단독 또는 페드라티닙 또는 룩솔리티닙과의 조합물의 용도

enthalten in: Europäisches Patentamt | 2023

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

4

USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2023

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

5

USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2022

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

6

USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2022

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

7

USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2022

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

8

BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2022

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

9

BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS

enthalten in: Europäisches Patentamt | 2022

von ARONCHIK IDA | BELTRAN VALENCIA ROXXANA VALERIA | CARRANCIO ANTON MARIA SORAYA | +9

10

BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors : Results from a Phase 1/2a Trial

enthalten in: Cancers | 2022

von Hilton, J. | Cristea, M. | Postel-Vinay, S. | +19